Browse articles from EyeWorld.org related to Nathan Radcliffe, MD. EyeWorld is the award-winning member publication of ASCRS. The magazine provides news and updates from the Society as well as clinical features in the areas of cataract, refractive, cornea, glaucoma, and practice management. It publishes quarterly with editorial direction from its medical editorial board and staff.
Glaucoma Editor Nathan Radcliffe, MD, spoke about EyeWorld’s approach to glaucoma management and introduced the new Glaucoma Editor, Manjool Shah, MD.
Glaucoma Editor Nathan Radcliffe, MD, shares a preview of the articles in the section.
Glaucoma Section Editor Nathan Radcliffe, MD, writes about the “chaotic events” that often thwart glaucoma patient care, how he thinks can help his patients become “antifragile,” how they can “grow from unpredictability and chaos.”
New innovations are entering the glaucoma space on a regular basis, but how do physicians discern whether (and when) to adopt them and what is that process like? Two physicians shared their considerations and experiences with bringing new techniques and technologies into practice.
EyeWorld Glaucoma Editor Nathan Radcliffe, MD, previews the articles in the Glaucoma section of the issue, specifically highlighting some of the advances and changes coming to the field.
Nathan Radcliffe, MD, shared his thoughts on the management of glaucoma and previewed the articles in the section.
“ASCRS and EyeWorld have been the cheerleaders of innovation in cataract and glaucoma surgery for many decades,” said Nathan Radcliffe, MD, Glaucoma editor said, adding later, “EyeWorld has been with me throughout my career to foster my drive for innovation.”
Ophthalmology will see its first major live meeting since the pandemic started with the 2021 ASCRS Annual Meeting. “Just as the live meeting will be reflective of our interesting times, this issue of EyeWorld is a product of our unique year, covering many topics that will help the modern ophthalmologist and glaucoma specialist succeed,” said Nathan Radcliffe, MD, Glaucoma editor.
Glaucoma Editor Nathan Radcliffe, MD, introduces the topics covered in the section, including early experience with Durysta, how other sustained therapies can benefit the glaucoma patient following cataract surgery, and how glaucoma care can be streamlined to keep everyone safe in the pandemic.
As I write this, we are in the ninth month of the COVID pandemic, and each day brings a record number of new cases in the third wave of the virus. As a glaucoma specialist in New York City, my practice has surely seen some ups and downs over the past year. We have had to adapt tremendously, and perhaps now is a good time to reflect on some of these changes.